900904.SHG Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B

Healthcare Pharmaceuticals Shanghai Stock Exchange
4.08 USD
Close of Nov 5, 2026
0.3920 0.5380
Market cap
USD 223M
P/E
-
P/B
0.65x
ROE
1.2%
Dividend yield
2.45%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 900904.SHG undervalued?

Graham number

The Graham number of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B fundamental analysis

No fundamental analysis for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B yet.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sales of pharmaceuticals in China and internationally. The company offers patented anti-tumor drugs; topical antibacterial series; products for hypertension, hyperlipidemia, and hyperglycemia chronic diseases; classic Chinese medicine cough relief series; classic tonic product series; Miao medicine for strengthening muscles and…

Full company profile